NCT00227617 2023-05-22
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
University of California, San Francisco
Phase 2/3 Terminated
University of California, San Francisco
Incyte Corporation
Gilead Sciences
Columbia University
H. Lee Moffitt Cancer Center and Research Institute
Chonnam National University Hospital
University of Alabama at Birmingham
Oncology Specialists, S.C.
Sanofi